CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $250,000 | -85.9% | 1,268,191 | -67.8% | 0.00% | -100.0% |
| Q3 2018 | $1,775,000 | -32.6% | 3,939,404 | -24.6% | 0.00% | 0.0% |
| Q2 2018 | $2,633,000 | +44.0% | 5,224,898 | +565.5% | 0.00% | 0.0% |
| Q1 2018 | $1,828,000 | -8.1% | 785,104 | +11.9% | 0.00% | 0.0% |
| Q4 2017 | $1,990,000 | -29.3% | 701,524 | -28.7% | 0.00% | -50.0% |
| Q3 2017 | $2,813,000 | -18.1% | 983,854 | -29.2% | 0.00% | 0.0% |
| Q2 2017 | $3,433,000 | -57.0% | 1,390,527 | -37.2% | 0.00% | -66.7% |
| Q1 2017 | $7,987,000 | +23.9% | 2,213,179 | +21.5% | 0.01% | +20.0% |
| Q4 2016 | $6,448,000 | -35.9% | 1,821,821 | -26.8% | 0.01% | -28.6% |
| Q3 2016 | $10,056,000 | -24.9% | 2,489,519 | -18.4% | 0.01% | -22.2% |
| Q2 2016 | $13,397,000 | +153.4% | 3,052,293 | +118.1% | 0.01% | +125.0% |
| Q1 2016 | $5,287,000 | -52.0% | 1,399,465 | +99.3% | 0.00% | -50.0% |
| Q4 2015 | $11,005,000 | -26.6% | 702,023 | -50.6% | 0.01% | -33.3% |
| Q3 2015 | $14,983,000 | -55.5% | 1,421,786 | +6.4% | 0.01% | -45.5% |
| Q2 2015 | $33,703,000 | -10.7% | 1,336,493 | -1.3% | 0.02% | -4.3% |
| Q1 2015 | $37,725,000 | +354.6% | 1,353,703 | +197.6% | 0.02% | +360.0% |
| Q4 2014 | $8,299,000 | +72.1% | 454,921 | +22.2% | 0.01% | +66.7% |
| Q3 2014 | $4,821,000 | -37.0% | 372,213 | -20.7% | 0.00% | -40.0% |
| Q2 2014 | $7,657,000 | -11.3% | 469,324 | -3.9% | 0.01% | -16.7% |
| Q1 2014 | $8,628,000 | -12.5% | 488,377 | +19.5% | 0.01% | -14.3% |
| Q4 2013 | $9,863,000 | -65.0% | 408,729 | -48.6% | 0.01% | -66.7% |
| Q3 2013 | $28,146,000 | – | 795,222 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |